He et al. found that AOF was a drug that could promote hippocampal nerve regeneration and improve cognitive deficits after stroke, and its mechanism might be related to its activation of the BDNF/TrkB/AKT signaling pathway [46]. The gene discussed is AKT1; the disease is Cognitive impairment.